MAINTAIN - MAintain Functions and INTrinsec capacities with Aging :
Preventive and personalized INterventional Research
Equipe constitutive du CERPOP, UMR 1295, unité mixte INSERM - Université Toulouse III Paul Sabatier Anaïs COURET • doctorante
Soutenance de thèse 15 décembre 2023
Publications :
UMR 1027
Poncet M, Gardette V, Couret A, Renoux A, Lapeyre-Mestre M, Gallini A. Benzodiazepine exposure in subjects with incident Alzheimer's disease and related syndromes in France: a longitudinal study 2011-2017. Int Clin Psychopharmacol. 2020;35(5):270-278. doi:10.1097/YIC.0000000000000312
Couret A, Gallini A, Poncet M, Renoux A, Lapeyre-Mestre M, Gardette V. Benzodiazepine Dispensing to Persons With Dementia in France, 2011-2016: A Nationwide Study. J Am Med Dir Assoc. 2020;21(6):830-836. doi:10.1016/j.jamda.2020.02.019
CERPOP
Gallini A, Jegou D, Lapeyre-Mestre M,Couret A, Bourrel R, Ousset PJ, Fabre D, Andrieu S, Gardette V. Development and Validation of a Model to Identify Alzheimer's Disease and Related Syndromes in Administrative Data. Curr Alzheimer Res. 2021;18(2):142-156. doi:10.2174/1567205018666210416094639
Couret A, Lapeyre-Mestre M, Gombault-Datzenko E, Renoux A, Villars H, Gardette V. Healthcare use patterns before Alzheimer's disease and related diseases identification and future healthcare trajectory. Int J Geriatr Psychiatry. 2023;38(1):e5849. doi:10.1002/gps.5849
Couret A, Lapeyre-Mestre M, Gombault-Datzenko E, Renoux A, Villars H, Gardette V. Which factors preceding dementia identification impact future healthcare use trajectories: multilevel analyses in administrative data. BMC Geriatr. 2024;24(1):89. Published 2024 Jan 23. doi:10.1186/s12877-023-04643-1
Couret A, Lapeyre-Mestre M, Renoux A, Gardette V. Healthcare use according to deprivation among French Alzheimer's Disease and Related Diseases subjects: a national cross-sectional descriptive study based on the FRA-DEM cohort. Front Public Health. 2024;12:1284542. Published 2024 Feb 29. doi:10.3389/fpubh.2024.1284542
Couret A, Gardette V, Renoux A, Lapeyre-Mestre M. Impact of modifications to antidementia drug reimbursement in France: Analysis of the FRA-DEM cohort. Br J Clin Pharmacol. Published online June 26, 2024. doi:10.1111/bcp.16143
Communications orales :
EPICLIN 2023 : Couret A, Lapeyre-Mestre M, Gombault-Datzenko E, Renoux A, Villars H, Gardette V, CO12.4 - Quels facteurs précédant le repérage de la démence impactent le futur parcours de soins ?, Revue d'Épidémiologie et de Santé Publique, Volume 71, Supplement 2, 2023, 101637, ISSN 0398-7620, https://doi.org/10.1016/j.respe.2023.101637.
EPICLIN 2024 : Couret A, Gardette V, Renoux A, Lapeyre-Mestre M, CO3.3 - Impact des modifications du remboursement des médicaments spécifiques de la maladie d'Alzheimer et maladies apparentées en France : analyse de la cohorte FRA-DEM, Journal of Epidemiology and Population Health, Volume 72, Supplement 2, 2024, 202409, ISSN 2950-4333, https://doi.org/10.1016/j.jeph.2024.202409.
Poster :
Congrès de la SFPT 2024 : Couret A, Gardette V, Renoux A, Lapeyre-Mestre M. Impact of reimbursement modification of anti-dementia drugs in France: analysis of the FRA-DEM cohort - Congrès de la Société Française de Pharmacologie et de Thérapeutique (SFPT) - Tours 2024.